TY - JOUR A2 - Di Lazzaro, Vincenzo AU - Aguirre-Velazquez, Carlos G. PY - 2017 DA - 2017/03/14 TI -报告了一项关于大麻二酚使用的父母调查(药用大麻)在墨西哥顽固性癫痫患儿中，SP - 2985729 VL - 2017采用AB结构在线调查，探讨了2016年9月墨西哥顽固性癫痫患儿的父母使用药用大麻的经历。对全部完成的调查进行了回顾，确定了53例9个月至18岁的儿童。其中，43例(82%)来自墨西哥，10例(18%)来自拉丁美洲国家。在43例墨西哥病例中，诊断如下:20例(47%)患有Lennox-Gastaut综合征(LGS);13例(30%)未指明的难治性癫痫(URE);西部综合征(WS) 8例(19%);Doose综合征(DS) 1例(2%);大田原综合征(OS) 1例(2%)。总计47.1%的病例曾接受过9种或以上的抗惊厥治疗。在81.3%的病例中，使用大麻二酚的父母惊厥次数减少; a moderate to significant decrease occurred in 51% of cases, and 16% of cases were free from seizure. The number of antiepileptic drugs being used was reduced in 9/43 (20.9%) cases. No serious adverse effects were reported, with only some mild adverse effects, such as increased appetite or changes in sleep patterns, reported in 42% of cases. SN - 2090-1852 UR - https://doi.org/10.1155/2017/2985729 DO - 10.1155/2017/2985729 JF - Neurology Research International PB - Hindawi KW - ER -